Prime Medicine Inc. Company Profile
NASDAQ: PRMEHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
3.90+0.40 (+11.43%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 3.90 0.00%
Prime Medicine at a glance
Prime Medicine Inc. (NASDAQ: PRME) is a Biotechnology: Biological Products (No Diagnostic Substances) company in the Health Care sector headquartered in Cambridge, MA. The company's shares have traded publicly since 2022. At a market capitalization of $634.8 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001894562, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
Company information
- Legal name
- Prime Medicine Inc.
- Ticker
- NASDAQ: PRME
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Headquarters
- 60 First St. 02141, Cambridge, MA, United States
- Phone
- 617-465-0013
- IPO year
- 2022
- Market cap
- $634.82M
- SEC CIK
- 0001894562
- Latest annual report
- 10-K · Mar 3, 2026
Companies similar to Prime Medicine
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| PROKProKidney Corp. Class A | 1.57 | -1.88% | $626.72M | vs PRME |
| DBVTDBV Technologies S.A. ADR | 9.77 | -2.10% | $614.03M | vs PRME |
| AURAAura Biosciences Inc. | 6.46 | +4.70% | $669.93M | vs PRME |
| ETRAElectra Therapeutics Inc. | 9.16 | -6.72% | $574.95M | vs PRME |
| FDMT4D Molecular Therapeutics Inc. | 12.59 | +0.24% | $695.52M | vs PRME |
| VALNValneva SE ADR | 5.87 | +0.17% | $556.61M | vs PRME |
| SLDBSolid Biosciences Inc. | 6.85 | -1.01% | $734.49M | vs PRME |
| ATTOAttovia Therapeutics Inc. | 16.42 | -6.17% | $749.59M | vs PRME |